Short-term or multi-period declines in USANA Health Sciences stock are typically driven by fluctuations in direct-sales active associate counts, regional macroeconomic headwinds in Asian international markets, shifting consumer discretionary spending trends, and varying quarterly revenue reports relative to Wall Street consensus expectations.